[
    [
        {
            "time": "2021-08-18",
            "original_text": "白云山(00874.HK)中期纯利25.02亿元 同比增长41.84%",
            "features": {
                "keywords": [
                    "白云山",
                    "中期纯利",
                    "同比增长",
                    "41.84%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(00874.HK)中期纯利25.02亿元 同比增长41.84%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "市场需求回升 白云山(00874)中期归母净利同比增41.84%至25.02亿元",
            "features": {
                "keywords": [
                    "市场需求",
                    "回升",
                    "白云山",
                    "归母净利",
                    "同比增长",
                    "41.84%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "市场需求回升 白云山(00874)中期归母净利同比增41.84%至25.02亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "白云山上半年净利润25亿同比增42%，王老吉收入60亿贡献4成利润",
            "features": {
                "keywords": [
                    "白云山",
                    "上半年净利润",
                    "同比增",
                    "42%",
                    "王老吉",
                    "收入60亿"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山上半年净利润25亿同比增42%，王老吉收入60亿贡献4成利润",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "白云山与广药集团订立业绩补偿补充协议",
            "features": {
                "keywords": [
                    "白云山",
                    "广药集团",
                    "业绩补偿",
                    "补充协议"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "白云山与广药集团订立业绩补偿补充协议",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "白云山：上半年实现净利25.02亿元 同比增长41.84%",
            "features": {
                "keywords": [
                    "白云山",
                    "上半年",
                    "净利",
                    "25.02亿元",
                    "同比增长",
                    "41.84%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山：上半年实现净利25.02亿元 同比增长41.84%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "快讯 | 白云山2021半年报：上半年营业收入约361.29亿元，同比增加18.57%",
            "features": {
                "keywords": [
                    "白云山",
                    "2021半年报",
                    "营业收入",
                    "361.29亿元",
                    "同比增加",
                    "18.57%"
                ],
                "sentiment_score": 0.87,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "快讯 | 白云山2021半年报：上半年营业收入约361.29亿元，同比增加18.57%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "市场需求回升 白云山(600332.SH)上半年归母净利同比增42%至25亿元",
            "features": {
                "keywords": [
                    "市场需求",
                    "回升",
                    "白云山",
                    "归母净利",
                    "同比增",
                    "42%",
                    "25亿元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "市场需求回升 白云山(600332.SH)上半年归母净利同比增42%至25亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "白云山(600332.SH)半年度净利润25.02亿元 同比增长41.84%",
            "features": {
                "keywords": [
                    "白云山",
                    "半年度净利润",
                    "25.02亿元",
                    "同比增长",
                    "41.84%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(600332.SH)半年度净利润25.02亿元 同比增长41.84%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "白云山半年报：上半年净利25亿元 同比增长42%",
            "features": {
                "keywords": [
                    "白云山",
                    "半年报",
                    "上半年净利",
                    "25亿元",
                    "同比增长",
                    "42%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山半年报：上半年净利25亿元 同比增长42%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]